UBS AM
GEVA

UBS AM’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

UBS AM’s Portfolio GEVA Stock Details GEVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$4.97M Buy
2014
Q4 		$4.42M Sell
2014
Q3 		$3.28M Sell
2014
Q2 		$5.23M Sell
2014
Q1 		$4.54M Sell
2013
Q4 		$3.92M Sell
2013
Q3 		$4M Buy
2013
Q2 		$2.37M Buy